A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Galapagos Nv stock. As of the latest transaction made, Citadel Advisors LLC holds 14,600 shares of GLPG stock, worth $391,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,600
Previous 7,400 97.3%
Holding current value
$391,280
Previous $183,000 129.51%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.2 - $30.67 $2.32 Million - $2.94 Million
-95,962 Reduced 62.34%
57,974 $1.67 Million
Q2 2024

Aug 14, 2024

BUY
$24.78 - $32.48 $3.28 Million - $4.3 Million
132,439 Added 616.08%
153,936 $3.81 Million
Q1 2024

May 15, 2024

SELL
$32.2 - $42.44 $7.76 Million - $10.2 Million
-240,887 Reduced 91.81%
21,497 $692,000
Q4 2023

Feb 14, 2024

SELL
$31.87 - $40.71 $6.61 Million - $8.45 Million
-207,484 Reduced 44.16%
262,384 $10.7 Million
Q3 2023

Nov 14, 2023

BUY
$34.17 - $42.98 $8.08 Million - $10.2 Million
236,577 Added 101.41%
469,868 $16.2 Million
Q2 2023

Aug 14, 2023

SELL
$37.4 - $44.52 $8.22 Million - $9.79 Million
-219,827 Reduced 48.51%
233,291 $9.49 Million
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $4.3 Million - $5.65 Million
117,687 Added 35.09%
453,118 $17.5 Million
Q4 2022

Feb 14, 2023

BUY
$37.44 - $46.51 $548,795 - $681,743
14,658 Added 4.57%
335,431 $14.9 Million
Q3 2022

Nov 14, 2022

BUY
$42.27 - $57.6 $68,435 - $93,254
1,619 Added 0.51%
320,773 $13.7 Million
Q2 2022

Aug 15, 2022

BUY
$52.3 - $71.59 $13.3 Million - $18.2 Million
254,162 Added 391.07%
319,154 $17.8 Million
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $23.4 Million - $31.2 Million
-455,196 Reduced 87.51%
64,992 $4.03 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $939,189 - $1.14 Million
19,970 Added 3.99%
520,188 $28.7 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $2.45 Million - $3.3 Million
47,039 Added 10.38%
500,218 $26.3 Million
Q2 2021

Aug 16, 2021

BUY
$68.86 - $83.34 $11.1 Million - $13.5 Million
161,512 Added 55.38%
453,179 $31.2 Million
Q1 2021

May 17, 2021

BUY
$76.15 - $111.94 $18.4 Million - $27 Million
241,449 Added 480.8%
291,667 $22.5 Million
Q4 2020

Feb 16, 2021

SELL
$96.85 - $148.25 $3.43 Million - $5.26 Million
-35,450 Reduced 41.38%
50,218 $4.97 Million
Q3 2020

Nov 16, 2020

BUY
$122.47 - $213.56 $6.98 Million - $12.2 Million
57,032 Added 199.16%
85,668 $12.2 Million
Q2 2020

Aug 14, 2020

BUY
$185.52 - $231.25 $505,542 - $630,156
2,725 Added 10.52%
28,636 $5.65 Million
Q1 2020

May 15, 2020

SELL
$143.0 - $274.03 $310,739 - $595,467
-2,173 Reduced 7.74%
25,911 $5.08 Million
Q4 2019

Feb 14, 2020

BUY
$146.12 - $215.82 $1.02 Million - $1.5 Million
6,957 Added 32.93%
28,084 $5.81 Million
Q3 2019

Nov 14, 2019

SELL
$130.44 - $187.64 $1.36 Million - $1.95 Million
-10,389 Reduced 32.96%
21,127 $3.23 Million
Q1 2019

May 15, 2019

BUY
$89.61 - $117.78 $1.52 Million - $2 Million
16,952 Added 116.4%
31,516 $0
Q4 2018

Feb 14, 2019

BUY
$87.81 - $110.65 $965,734 - $1.22 Million
10,998 Added 308.41%
14,564 $1.34 Million
Q1 2018

May 11, 2018

BUY
$94.51 - $120.23 $65,778 - $83,680
696 Added 24.25%
3,566 $356,000
Q4 2017

Feb 09, 2018

SELL
$84.48 - $104.02 $955,384 - $1.18 Million
-11,309 Reduced 79.76%
2,870 $269,000
Q3 2017

Nov 09, 2017

BUY
$73.17 - $103.47 $1.04 Million - $1.47 Million
14,179
14,179 $1.44 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.